Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substancenews2024-05-29T13:45:41+00:00May 29th, 2024|Medical Device News Magazine|
Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhDnews2024-05-24T16:27:41+00:00May 24th, 2024|Medical Device News Magazine|
Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startupsnews2024-05-23T19:21:04+00:00May 23rd, 2024|Medical Device News Magazine|
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)news2024-05-15T13:02:51+00:00May 15th, 2024|Medical Device News Magazine|
AbbVie and Gilgamesh Pharmaceuticals | Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disordersnews2024-05-13T15:03:07+00:00May 13th, 2024|Medical Device News Magazine|
PharmaLogic Announces Opening of Radiopharmaceutical Production Facility in New York Citynews2024-05-13T15:00:01+00:00May 13th, 2024|Medical Device News Magazine|
Ossium Health Launches HOPE Program to Give All Patients Hope for a Curenews2024-05-10T19:10:58+00:00May 10th, 2024|Medical Device News Magazine|
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatmentsnews2024-05-06T19:45:05+00:00May 6th, 2024|Medical Device News Magazine|
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessmentnews2024-05-02T16:19:59+00:00May 2nd, 2024|Medical Device News Magazine|
Unleashing Biotech Potential: ATLATL Scientific & Miltenyi Biotec Partnershipnews2024-04-30T18:11:04+00:00April 30th, 2024|Medical Device News Magazine|
